Height, leg length, and cancer risk: A systematic review

Epidemiologic Reviews

Volumn 23, Issue 2, 2001, Pages 313-342

  Mehta, Shruti H ^a   Strathdee, Steffanie A ^a   L thomas, David ^a,b,c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; BODY HEIGHT; CANCER RISK; CANCER SUSCEPTIBILITY; CIGARETTE SMOKING; DISEASE PREDISPOSITION; DNA DAMAGE; ENVIRONMENTAL EXPOSURE; GENOTYPE; HUMAN; LEG LENGTH; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0035685665     PISSN: 0193936X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.epirev.a000809     Document Type: Review

References (336)

1. Adult height and incidence of cancer in male physicians (United States)
2. Height and risk of death among men and women: Aetiological implications of associations with cardiorespiratory disease and cancer mortality
3. Height and mortality in the counties of England and Wales
4. International differences in body height and weight and their relationship to cancer incidence
5. Breast cancer in Europe: The importance of factors operating at an early age
6. Diet, body build, and breast cancer
7. A woman's build and the risk of breast cancer
8. Dietary factors and risk of breast cancer: Combined analysis of 12 case-control studies
9. Environment and cancer: Who are susceptible?
10. How cancer arises
11. Cancer: Looking outside the genome
12. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study
13. Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer
14. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: A prospective study
15. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer
16. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-1 and IGF-binding protein-3
17. Plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women
18. The relationship between dietary fat intake and risk of colorectal cancer: Evidence from the combined analysis of 13 case-control studies
19. A pooled analysis of thyroid cancer studies. V. Anthropometric factors
20. Anthropometry, body composition, and cancer
21. Relationship between height, sitting height and subischial leg length in Dutch children: Presentation of normal values
22. Leg length and risk of cancer in the Boyd Orr cohort
23. Socio-economic and dietary influences on leg length and trunk length in childhood: A reanalysis of the Carnegie (Boyd Orr) survey of diet and health in prewar Britain (1937-39)
24. Adult stature and risk of cancer
25. Early precursors of site-specific cancers in college men and women
26. A prospective study of weight, body mass index and other anthropometric measurements in relation to site-specific cancers
27. Obesity in youth and middle age and risk of colorectal cancer in men
28. Body height and lung cancer risk
29. Adult height and mortality in London: Early life, socioeconomic confounding, or shrinkage?
30. Physical activity, obesity, and risk for colon cancer and adenoma in men
31. Risk factors for malignant diseases: A cohort study on a population of 22,946 Icelanders
32. A prospective study of body mass, height, and smoking on the risk of colorectal cancer in women
33. Height, weight, and risk of colorectal cancer
34. Sugar, meat, and fat intake, and non-dietary risk factors for colon cancer incidence in Iowa women (United States)
35. Height, weight and gastrointestinal cancer: A follow-up study in Norway
36. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women
37. Age at menopause, body mass index, and the risk of colorectal cancer mortality in the Dutch Diagnostisch Onderzoek Mammacarcinoom (DOM) cohort
38. Epidemiology of sociodemographic characteristics, lifestyle, medical history, and colon cancer: A case-control study among French Canadians in Montreal
39. Diet, physical activity, and colorectal cancer among Chinese in North America and China
40. Height and cancer risk in a network of case-control studies from northern Italy
41. The association of body size and large bowel cancer risk in Wisconsin (United States) women
42. Body size and the risk of colon cancer in a large case-control study
43. IGF-I and IGF-II in relation to colorectal cancer
44. Biosocial correlates of colorectal cancer in Greece
45. A case-control study of relationships of diet and other traits to colorectal cancer in American blacks
46. Etiological factors in gastrointestinal cancer in man
47. Incidence of cancer of the large bowel in women in relation to reproductive and hormonal factors
48. Body size and colorectal-cancer risk
49. A case-control study of diet and rectal cancer in western New York
50. A case-control study of diet and colo-rectal cancer
51. Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer
52. A case-control study of occupational and dietary factors in colorectal cancer in young men by subsite
53. Physical and demographic features of men before developing cancer of the prostate
54. Animal fat consumption and prostate cancer: A prospective study in Hawaii
55. Prostate cancer risk in relation to anthropometry and physical activity: The National Health and Nutrition Examination Survey I Epidemiological Follow-up Study
56. Height, body weight, and risk of prostate cancer
57. Association of smoking, body mass, and physical activity with risk of prostate cancer in the Iowa 65+ Rural Health Study (United States)
58. Dietary fat intake and risk of prostate cancer: A prospective study of 25,708 Norwegian men
59. Body size and prostate cancer: A 20-year follow-up study among 135,006 Swedish construction workers
60. Anthropometry and prostate cancer risk: A prospective study of 22,248 Norwegian men
61. Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study
62. Body size, age at shaving initiation, and prostate cancer in a large, multiracial cohort
63. Lifestyle and anthropometric risk factors for prostate cancer in a cohort of Iowa men
64. Physical activity and the risk of prostate and testicular cancer: A cohort study of 53,000 Norwegian men
65. Dietary factors and risks for prostate cancer among blacks and whites in the United States
66. Serum steroids in relation to prostate cancer risk in a case-control study (Greece)
67. Physical characteristics and factors related to sexual development and behaviour and the risk for prostatic cancer
68. Early life risk factors for prostate cancer: A population-based case-control study in Sweden
69. Lifestyle factors and prostate cancer risk: A case-control study in Sweden
70. Epidemiology of prostatic cancer: A case-control study
71. Height-related risk factors for prostate cancer
72. Smoking and obesity in relation to the etiology and disease progression of prostate cancer in Japan
73. Body size and prostate cancer: A population-based case-control study in China
74. Case-control study of prostate cancer in black patients in Soweto, South Africa
75. Risk factors for prostate cancer: Results from the Canadian National Enhanced Cancer Surveillance System
76. Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada
77. Diet and prostatic cancer: A case-control study in Hawaii
78. Characteristics of patients with prostatic carcinoma: A control case study on 83 autopsy pairs
79. Epidemiology of cancer of the prostate
80. Nutrition, social factors and prostatic cancer in a Northern Italian population
81. Case-control studies of prostate cancer in blacks and whites in southern California
82. Vasectomy, cigarette smoking, and age at first sexual intercourse as risk factors for prostate cancer in middle-aged men
83. Beta-carotene and animal fats and their relationship to prostate cancer risk: A case-control study
84. Body dimension differences in men with or without prostate cancer
85. Prostatic tumors (adenoma, adenocarcinoma) and obesity in Cameroon
86. Anthropometric risk factors for prostate cancer
87. A case-control study of diet and prostate cancer
88. Risk factors for prostate cancer: A case-control study in Greece
89. Anthropometric measures and metabolic rate in association with risk of breast cancer (United States)
90. Breast cancer risk assessed by anthropometry in the NHANES I Epidemiological Follow-up Study
91. Adolescence and breast carcinoma risk
92. Prospective study of relative weight, height, and risk of breast cancer
93. Anthropometric predictors of breast cancer incidence and survival in a multi-ethnic cohort of female residents of Hawaii, United States
94. Body size at different periods of life and breast cancer risk
95. Body fat distribution in relation to breast cancer in women participating in the DOM-project
96. Breast-cancer incidence in relation to height, weight and body-fat distribution in the Dutch "DOM" cohort
97. Body height and risk of breast cancer: A prospective study of 23,831 Norwegian women
98. Prospective study of height, body mass index and risk of breast cancer
99. The association of height, weight, menstrual and reproductive events with breast cancer: Results from two prospective studies on the island of Guernsey (United Kingdom)
100. A prospective study in general practice breast-cancer risk in postmenopausal women
101. Height, weight, weight change, and postmenopausal breast cancer risk: The Netherlands Cohort Study
102. Epidemiology of breast cancer in a screened population
103. Breast cancer risk in relation to serum cholesterol, serum beta lipoprotein, height, weight, and blood pressure
104. Consumption of meat, animal products, protein, and fat and risk of breast cancer: A prospective cohort study in New York
105. Height and weight in relation to breast cancer morbidity and mortality: A prospective study of 570,000 women in Norway
106. Increased incidence of carcinoma of the breast associated with abdominal adiposity in postmenopausal women
107. Relationship of childhood height and risk of breast cancer
108. Obesity, weight change, fasting insulin, proinsulin, C-peptide, and insulin-like growth factor-1 levels in women with and without breast cancer: The Rancho Bernardo Study
109. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk
110. Height and weight at various ages and risk of breast cancer
111. Comparative case-referent study of risk factors among hormone related female cancers in Japan
112. Body size and breast cancer risk assessed in women participating in the Breast Cancer Detection Demonstration Project
113. Case-controlled study of the epidemiological risk factors for breast cancer in Nigeria
114. Age at menarche, age at menopause, height and obesity as risk factors for breast cancer: Associations and interactions in an international case-control study
115. Characteristics that predict risk of breast cancer before and after the menopause
116. Epidemiologic features of breast cancer in Slovenia, 1965-1967
117. Breast cancer and body build
118. Lactation and reproductive histories of breast cancer patients in Greater Athens, 1965-67
119. Body sire and risk of pre-and post-menopausal breast cancer in Taiwan
120. Breast cancer incidence according to weight and height in two cities of the Netherlands and in Aichi prefecture, Japan
121. Height as a determinant of breast cancer risk in a study of Asian-American women
122. Body size and breast cancer risk in black women and white women
123. Relationships of body size with breast cancer
124. Nutrition and breast cancer risk in Japan
125. Body size in different periods of life and breast cancer risk in post-menopausal women
126. Breast cancer in Australian women under the age of 40
127. Risk factors for breast carcinoma in Singaporean Chinese women: The role of central obesity
128. Body size and breast cancer risk among women under age 45 years
129. Body size and risk of breast cancer
130. Relative weight, weight change, height, and breast cancer risk in Asian-American women
131. Adult height and risk of breast cancer among US black women
132. Breast cancer incidence and nutritional status with particular reference to body weight and height
133. Association of body mass index, physical activity and reproductive histories with breast cancer: A case-control study in Gifu, Japan
134. Risk factors for breast cancer among Japanese women in Tokyo: A case-control study
135. Risk factors for breast cancer according to age at diagnosis in a French case-control study
136. Epidemiologic characteristics of cancer of the breast in Taiwan
137. Epidemiologic characteristics of breast cancer in three menopausal stages: Preliminary findings
138. Risk factor for breast cancer in Japan, with special attention to anthropometric measurements and reproductive history
139. Body measurements, estrogen availability and the risk of human breast cancer: A case-control study
140. Sociodemographic characteristics, smoking, medical and family history and breast cancer
141. Childhood and recent eating patterns and risk of breast cancer
142. Anthropometric indicators of breast cancer risk in postmenopausal women in Hawaii
143. Anthropometric measures and breast cancer in young women
144. Body-size indicators and risk of breast cancer according to menopause and estrogen-receptor status
145. Relation between anthropometric indicators and risk of breast cancer among Australian women
146. Risk factors of breast cancer in Finland
147. Height and weight, mammographic features of breast tissue, and breast cancer risk
148. Insulin and related factors in premenopausal breast cancer risk
149. An anthropometric study of women with cancer
150. Anthropometric variables and risk of breast cancer
151. Risk factors for breast cancer in women undergoing mammography
152. The significance of physical activity and anthropometric parameters for the development of breast cancer
153. Breast cancer in an area of high parity: Sao Paulo, Brazil
154. An epidemiologic study of breast cancer
155. Anthropometric variables in relation to risk of breast cancer in middle-aged women
156. Breast cancer in relation to weight in women aged 65 years and over
157. Body size as a factor in different ages and breast cancer risk in Taiwan
158. Body size indices and breast cancer risk before and after menopause
159. Anthropometric indicators of breast cancer risk in Japanese women in Fukuoka
160. Importance of anthropometric parameters in breast cancer
161. Breast carcinoma and skeletal formation
162. A case-control study on breast cancer and body mass
163. Height and breast cancer risk
164. The epidemiology of breast cancer in 785 United States Caucasian women
165. Adult height and risk of breast cancer among white women in a case-control study
166. Influence of height, weight and obesity on risk of breast cancer in an unselected Swedish population
167. The relationship between body mass and breast cancer among women enrolled in the Cancer and Steroid Hormone Study
168. Influence of non-contraceptive exogenous and endogenous sex hormones on breast cancer risk in Denmark
169. Obesity and breast disease: The role of female sex hormones
170. Age when maximum height is reached as a risk factor for breast cancer among young U.S. women
171. Overweight and changes in weight throughout adult life in breast cancer etiology: A case-control study
172. Reproductive factors and breast cancer in New Zealand
173. Influence of height, weight and obesity on breast cancer incidence and recurrence in Auckland, New Zealand
174. Relation between obesity and breast cancer in young women
175. Abdominal obesity and breast cancer risk
176. Early adult body weight, body mass index and premenopausal bilateral breast cancer: Data from a case-control study
177. Nutrition and carcinoma of the breast: Presentation of a French investigation
178. Breast cancer risk factors in women in Santiago, Chile
179. Influence of energy intake and body mass index in the incidence of cancer of the breast: Case-control study in a sample from 3 Spanish hospital populations
180. The association of increased weight, body mass index, and tissue density with the risk of breast carcinoma in Vermont
181. Risk factor analysis of data from assessment clinics in the UK Breast Screening Programme: A case-control study in Portsmouth and Southampton
182. Leptin and insulin growth factor I in relation to breast cancer (Greece)
183. A case control study of endometrial cancer within a cohort
184. Height and weight in relation to uterine corpus cancer morbidity and mortality: A follow-up study of 570,000 women in Norway
185. Endometrial cancer in a cohort screened for breast cancer
186. Early-age body size, adult weight gain and endometrial cancer risk
187. A case-control study of endometrial cancer in relation to reproductive, somatometric, and life-style variables
188. A case-control study of cancer of endometrium in Athens
189. Diet, body size, physical activity, and the risk of endometrial cancer
190. Nutritional factors and pancreatic cancer in the francophone community in Montreal, Canada
191. Reproductive, menstrual, and medical risk factors for endometrial cancer: Results from a case-control study
192. An epidemiological investigation of cancer of the endometrium
193. Epidemiology of endometrial cancer
194. A population-based case-control study of endometrial cancer in Shanghai, China
195. Endometrial cancer following treatment for breast cancer: A case-control study in Denmark
196. Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden)
197. Relation of endometrial cancer risk to past and contemporary body size and body fat distribution
198. Endometrial carcinoma: A retrospective, epidemiological study
199. Association between teen-age obesity and cancer in 56,111 women: All cancers and endometrial carcinoma
200. The joint effect of risk factors on endometrial cancer
201. Anthropometric indicators of endometrial cancer risk
202. Role of diet in endometrial cancer patients
203. Upper-body fat distribution and endometrial cancer risk
204. Body mass index, weight gain, and risk of endometrial cancer
205. Dietary fat and protein in relation to risk of non-Hodgkin's lymphoma among women
206. Height and Hodgkin's disease
207. Increased prevalence of minor anomalies in childhood malignancy
208. Height at diagnosis in acute lymphocytic leukaemia
209. Height and lymphoblastic leukaemia
210. Height and lymphoblastic leukemia
211. Height of children successfully treated for acute lymphoblastic leukemia: A report from the Late Effects Study Committee of Childrens Cancer Study Group
212. Nutrition and growth in children with acute lymphoblastic leukemia (ALL)
213. Poor prognosis of acute lymphoblastic leukaemia in Asian children living in the United Kingdom
214. Growth in children with acute lymphocytic leukemia: A Pediatric Oncology Group study
215. Height, weight and cancer of the oesophagus and stomach: A follow-up study in Norway
216. Dietary factors and the incidence of cancer of the stomach
217. Early-life risk indicators of gastric cancer: A population-based case-control study in Sweden
218. Body mass index and the risk of cancers of the gastric cardia and distal stomach in Shanghai, China
219. Association between body mass and adenocarcinoma of the esophagus and gastric cardia
220. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia
221. Pre-morbid height and weight as risk factors for development of central nervous system neoplasms
222. An exploratory case-control study of brain tumors in children
223. Body size and cancer of the testis
224. Body size and testicular cancer
225. Social, behavioural and medical factors in the aetiology of testicular cancer: Results from the UK study
226. Physical activity, medical history, and risk of testicular cancer (Alberta and British Columbia, Canada)
227. Cutaneous malignant melanoma: Association with height, weight and body-surface area. A prospective study in Norway
228. Diet and risk of cutaneous malignant melanoma: A prospective study of 50,757 Norwegian men and women
229. Risk factors associated with uterine cervical cancer in Korea: A case-control study with special reference to sexual behavior
230. Height and mortality from cancer among men: Prospective observational study
231. Height and cancer mortality: Results from the Glasgow university student cohort
232. Childhood leg length and adult mortality: Follow up of the Carnegie (Boyd Orr) Survey of Diet and Health in Pre-War Britain
233. The association of body size, reproductive factors and thyroid cancer
234. An epidemiologic study of thyroid cancer in Hawaii
235. Risk factors for male breast cancer
236. A case-control study of male breast cancer
237. Breast cancer in men: Risk factors with hormonal implications
238. Risk factors for male breast cancer
239. Dietary factors and epithelial ovarian cancer
240. The epidemiology of ovarian cancer in Greece: A case-control study
241. Anthropometric and other risk factors for ovarian cancer in a case-control study
242. A case-control study of ovarian cancer to identify its risk factors
243. Growth and development and other risk factors for osteosarcoma in children and young adults
244. Stature and malignant tumors of bone in childhood and adolescence
245. A case-control study of osteosarcoma in young persons
246. Longitudinal growth and dental developments in osteosarcoma patients
247. Prognostic factors in osteosarcoma: A review of 20 years' experience at the University of Pittsburgh Health Center Hospitals
248. Stature and Ewing's sarcoma in childhood
249. Identification of risk factors for diethyl-stilbestrol-associated clear cell adenocarcinoma of the vagina: Similarities to endometrial cancer
250. Energy expenditure in patients with hepatocellular carcinoma
251. Body weight and risk of soft-tissue sarcoma
252. Non-occupational risk factors for adult soft-tissue sarcoma in northern Italy
253. A case-control study of soft-tissue sarcoma
254. Body height and lung cancer risk
255. Body height and lung cancer risk
256. Association of body mass index and body fat distribution with risk of lung cancer in older women
257. Relation of body size and the risk of lung cancer
258. Body mass index and lung cancer risk
259. Body height and lung cancer risk
260. Anthropometric measures and risk of cancers of the upper digestive and respiratory tract
261. Risk factors for pancreatic cancer: An exploratory study
262. Anthropometric and reproductive variables and exocrine carcinoma of the pancreas: A population-based case-control study in the Netherlands
263. Anthropometric and reproductive factors and the risk of pancreatic cancer: A case-control study in Shanghai, China
264. Epidemiological study of risk factors for bladder cancer
265. The role of obesity and weight fluctuations in the etiology of renal cell cancer: A population-based case-control study
266. International renal-cell cancer study. III. Role of weight, height, physical activity, and use of amphetamines
267. Risk factors for renal-cell carcinoma in Denmark. III. Role of weight, physical activity and reproductive factors
268. Obesity and risk of renal cell cancer
269. Height at diagnosis of malignancies
270. Height and the prevalence of chronic disease
271. Body mass and prostatic cancer: A prospective study
272. La patologia della leucemia acuta infantile
273. Risk factors of testicular cancer: A case-control study in twins
274. Social class and cancer survival in Turin, Italy
275. Can self-reported data accurately describe the prevalence of overweight?
276. Height and risk of cancer: Survival selection bias should have been ruled out
277. Height and risk of cancer - Authors' reply
278. Twin growth: Initial deficit, recovery, and trends in concordance from birth to nine years
279. Relative effect of genetic and environmental factors on body height: Differences across birth cohorts among Finnish men and women
280. Twin studies in medical research: Can they tell us whether diseases are genetically determined?
281. Parent-child correlations for stature and weight among school aged children: A review of 24 studies
282. Identification of novel human GH-1 gene polymorphisms that are associated with growth hormone secretion and height
283. Identification of short stature caused by SHOX defects and therapeutic effect of recombinant human growth hormone
284. Deletion of 8.5 Mb, including the FMR1 gene, in a male with the fragile X syndrome phenotype and overgrowth
285. Mutations in the growth hormone releasing hormone receptor: A new form of dwarfism in humans
286. Retarded growth, life span, ultimate body size and age changes in the albino rat after feeding diets restricted in calories
287. Dietary restrictions and cancer
288. Childhood energy intake and adult cancer - The Boyd Orr cohort study
289. Clues to the aetiology of testicular germ cell tumours from descriptive epidemiology
290. Infections in childhood and pregnancy as a cause of adult disease - Methods and examples
291. Oxford Child Health Survey. Effect of childish ailments on skeletal development
292. Growth in early childhood in developing countries
293. Helicobacter pylori infection and growth delay in older children
294. Association between infection with Helicobacter pylori and risk of gastric cancer: Evidence from a prospective investigation
295. Hodgkin's disease in adults: Association with social factors and age at tonsillectomy. A case-control study
296. Mental contentment and physical growth
297. Family conflict and slow growth
298. Birthweight as a risk factor for breast cancer
299. High birthweight as a predictor of prostate cancer risk
300. Is cancer causation simpler than we thought, but more intractable?
301. Growth from birth to adult life of 442 Newcastle upon Tyne children
302. Failure to realise growth potential in utero and adult obesity in relation to blood pressure in 50-year-old Swedish men
303. Separating in-utero and postnatal influences on later disease
304. Age at menarche: Secular trends and its association with adult anthropometric measures
305. Relationship between menarcheal age and adult height
306. Are cell number and cell proliferation risk factors for cancer?
307. Cellular response in rats during malnutrition at various ages
308. Alcohol, height, and adiposity in relation of estrogen and prolactin levels in postmenopausal women
309. Associations of alcohol, height, and reproductive factors with serum hormone concentrations in postmenopausal Japanese women
310. Serum hormone levels in relation to reproductive and lifestyle factors in post-menopausal women (United States)
311. Serological precursors of cancer - Serum hormones and risk of subsequent prostate-cancer
312. Prospective study of sex hormone levels and risk of prostate cancer
313. Size at birth and plasma insulin-like growth factor-1 concentrations
314. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: The relation to IGF-I, IGF-II, IFGBP-1, IGFBP-2, age, sex, body mass index and pubertal maturation
315. Insulin-like growth factors
316. Plasma levels of insulin-like growth factor-I and lung cancer risk: A case-control analysis
317. Acromegaly
318. Acromegaly and gastrointestinal cancer
319. Mortality and cancer incidence in acromegaly: A retrospective cohort study
320. The little women of Loja - Growth hormone-receptor deficiency in an inbred population of southern Ecuador
321. Growth curves for Laron syndrome
322. Growth hormone, IGF-I and cancer. Less intervention to avoid cancer? More intervention to prevent cancer?
323. Insulin-like growth factor-I and new opportunities for cancer prevention
324. Cancer and insulin-like growth factor-I: A potential mechanism linking the environment with cancer risk
325. Growth hormone treatment induces mammary gland hyperplasia in aging primates
326. In vitro effects of growth hormone (GH) and insulin-like growth factor I and II (IGF-I and -II) on chromosome fragility and p53 protein expression in human lymphocytes
327. Nutritional regulation of insulin-like growth factor-I
328. The pathophysiology of the insulin-like growth factor axis in fetal growth failure: A basis for programming by undernutrition
329. Effect of human growth hormone treatment for 1 to 7 years on growth of 100 children, with growth hormone deficiency, low birth-weight, inherited smallness, Turner's syndrome, and other complaints
330. Lifestyle factors and insulin-like growth factor 1 levels among elderly men
331. Epidemiology of insulin-like growth factor-I in elderly men and women: The Rancho Bernardo Study
332. Height, weight and mortality: The Norwegian experience
333. Tobacco, ethanol, coffee, pancreatitis, diabetes mellitus and cholelithiasis as risk factors for pancreatic carcinoma
334. A collaborative case-control study of nutrient intake and pancreatic cancer within the SEARCH programme